Digest Network Come funziona
Network
/
Società
Co
Non verificato

Compass Pathways plc

Di cosa scriviamo

BiotecnologiaFarmaceuticaMedicina - VariePsichiatriaSalute

14 comunicati stampa

Guarda tutti i comunicati
22/04/2025
Industria
Psichiatria
Salute
Medicina - Varie
Scienza
Farmaceutica
Biotecnologia
Compass Pathways Announces Dosing Complete for All Participants in Part A of Phase 3 COMP005 Trial of COMP360 Psilocybin for Treatment-Resistant Depression
Fonte
Compass Pathways plc
Emittente
Business Wire
1.00
0
26/03/2025
Industria
Scienza
Biotecnologia
Farmaceutica
Sanità
Salute
Psichiatria
Medicina - Varie
Compass Pathways Announces Completion of Recruitment for the Phase 3 COMP005 Trial of COMP360 Psilocybin for Treatment-Resistant Depression
Fonte
Compass Pathways plc
Emittente
Business Wire
1.00
0
18/03/2025
Industria
Scienza
Biotecnologia
Farmaceutica
Sanità
Salute
Psichiatria
Medicina - Varie
Compass Pathways Announces Publication of Results from COMP004 Study on COMP360 Psilocybin for Treatment-Resistant Depression
Fonte
Compass Pathways plc
Emittente
Business Wire
1.00
0
11/03/2025
Web e Social Network
Eventi
Psichiatria
Scienza
Medicina - Varie
Biotecnologia
Sanità
Salute
Compass Pathways to Participate in Stifel Virtual CNS Forum
Fonte
Compass Pathways plc
Emittente
Business Wire
1.00
0
27/02/2025
Biotecnologia
Farmaceutica
Salute
Psichiatria
Web e Social Network
Telefonia e Varie
Mercato azionario
Compass Pathways Announces Fourth Quarter and Full-Year 2024 Financial Results and Business Highlights
Fonte
Compass Pathways plc
Emittente
Business Wire
1.00
0
25/02/2025
Biotecnologia
Farmaceutica
Salute
Psichiatria
Web e Social Network
Eventi
Fiere
Compass Pathways to Participate in TD Cowen 45th Annual Health Care Conference
Fonte
Compass Pathways plc
Emittente
Business Wire
1.00
0
18/02/2025
Web e Social Network
Telefonia e Varie
Finanza
Mercato azionario
Medicina alternativa
Psichiatria
Salute
Sanità
Medicina - Varie
Farmaceutica
Biotecnologia
Compass Pathways to announce fourth quarter and year-end financial results on February 27th, 2025
Fonte
Compass Pathways plc
Emittente
Business Wire
1.00
0
05/02/2025
Psichiatria
Scienza
Medicina - Varie
Biotecnologia
Sanità
Salute
Eventi
Web e Social Network
Compass Pathways to Participate in Oppenheimer 35th Annual Healthcare Life Sciences Conference
Fonte
Compass Pathways plc
Emittente
Business Wire
1.00
0
21/01/2025
Mercato del lavoro
Scienza
Psichiatria
Finanza
Medicina - Varie
Associazioni/Professionisti
Biotecnologia
Sanità
Salute
Compass Pathways Appoints Steve Levine, M.D., as Chief Patient Officer
Fonte
Compass Pathways plc
Emittente
Business Wire
1.00
0
10/01/2025
Finanza
Psichiatria
Salute
Medicina - Varie
Farmaceutica
Biotecnologia
Compass Pathways Announces Pricing of Underwritten Offering
Fonte
Compass Pathways plc
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0